Details of the Drug Formulations

General Information of Drug (ID: DMG9B1U)

Drug Name
Elvitegravir Drug Info
Synonyms EVG
Indication
Disease Entry ICD 11 Status REF
Human immunodeficiency virus infection 1C62 Approved [1]
Cross-matching ID
PubChem CID
5277135
ChEBI ID
CHEBI:72289
CAS Number
697761-98-1
TTD ID
D0QD1G
INTEDE ID
DR0570
ACDINA ID
D00227

Full List of Drug Formulations Containing This Drug

Elvitegravir 150 mg tablet
Company Formulation ID FDA Description
Gilead Sciences F07205 Lactose monohydrate; Sodium lauryl sulfate; Fd&c blue no. 2; Magnesium stearate; Ferric oxide yellow; Talc; Titanium dioxide; Water; Croscarmellose sodium; Polyethylene glycol 3350; Polyvinyl alcohol; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h)
------------------------------------------------------------------------------------
Elvitegravir 85 mg tablet
Company Formulation ID FDA Description
Gilead Sciences F07206 Lactose monohydrate; Sodium lauryl sulfate; Fd&c blue no. 2; Magnesium stearate; Ferric oxide yellow; Talc; Titanium dioxide; Water; Croscarmellose sodium; Polyethylene glycol 3350; Polyvinyl alcohol; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h)
------------------------------------------------------------------------------------

References

1 Radium 223 dichloride for prostate cancer treatment. Drug Des Devel Ther. 2017 Sep 6;11:2643-2651.